BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Human chorionic gonadotropin
,
Ciprofibrate
,
rs2476601
,
EGFR
,
Angiogenesis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
VEGFR 3
Summary
General Info
Curated Studies
Most Correlated Studies
HUVECs treated with doxorubicin (topoisomerase-2 inhibitor) or with axitinib (VEGFRs inhibitor)
Endothelial colony forming cells as precursors of blood and lymphatic endothelium
Pulmonary Hypertension in a Rodent Model 1
Hemangioendothelioma cell line gene profiling with Prox1 overexpression
Glomeruli gene expression profiling of mice with type 1 or type 2 diabetes
Explore Curated Studies Results
Literature
Most Relevant Literature
Morphometric image analysis of vascular endothelial growth factor receptor-3 in preeclamptic, HIV in…
Investigation of Targeting Relationship between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcin…
Primary Preclinical and Clinical Evaluation of 68Ga-DOTA-TMVP1 as a Novel VEGFR-3 PET Imaging Radiot…
HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-3…
Formation of the glomerular microvasculature is regulated by VEGFR-3.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors
Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Advers…
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
Electrical Stimulation and Expression of VEGF, VEGFR-2, HIF and NO in the Diabetic Foot Ulcer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ